학술논문
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA
Document Type
Article
Author
Source
In: Clinical Drug Investigation . (Clinical Drug Investigation, June 2022, 42(6):501-511)
Subject
Language
English
ISSN
11791918
11732563
11732563